Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 1,4 Diazacyclohexane
2. 1,4 Piperazine
3. 1,4-diazacyclohexane
4. 1,4-piperazine
5. Piperazine
6. Piperazine Diacetate
7. Piperazine Dihydrochloride
8. Piperazine Hydrate
9. Piperazine Hydrobromide
10. Piperazine Hydrochloride
11. Piperazine Monohydrochloride
12. Piperazine Phosphate
13. Piperazine Phosphate (1:1)
14. Piperazine Phosphate Anhydrous
15. Piperazine Salt
16. Piperazine Sulfate
17. Piperazine Tartrate
18. Piperazine Tartrate (1:1), (r-(r*,r*))-isomer
19. Piperazine Tartrate, (r-(r*,r*))-isomer
20. Piperazinium Oleate
21. Pripsen
1. 142-63-2
2. Arthriticine
3. Piperazine, Hexahydrate
4. Vermisol
5. Parid
6. Piperazine;hexahydrate
7. Piperazine (hexahydrate)
8. P3m07b8u64
9. Piperazinehexahydrate
10. Usaf A-3803
11. Mfcd00149389
12. Diethylenediamine Hexahydrate
13. Unii-p3m07b8u64
14. Ai3-26675
15. Vermyl (tn)
16. Hy-b0912a
17. Dtxsid50161918
18. 1,4-piperazine Hexahydrate
19. Piperazine Hexahydrate [ii]
20. Piperazine Hexahydrate [mi]
21. Piperazine Hydrate [mart.]
22. Piperazine, Hydrate (1:6)
23. Piperazine Hexahydrate [vandf]
24. Akos000121857
25. Cs-7631
26. Piperazine Hexahydrate [who-dd]
27. Ls-13032
28. Piperazine Hexahydrate, Analytical Standard
29. Ft-0689820
30. D08381
31. J-007675
32. Q3905511
33. Piperazine Hydrate, European Pharmacopoeia (ep) Reference Standard
| Molecular Weight | 194.23 g/mol |
|---|---|
| Molecular Formula | C4H22N2O6 |
| Hydrogen Bond Donor Count | 8 |
| Hydrogen Bond Acceptor Count | 8 |
| Rotatable Bond Count | 0 |
| Exact Mass | 194.14778643 g/mol |
| Monoisotopic Mass | 194.14778643 g/mol |
| Topological Polar Surface Area | 30.1 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 26.5 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 7 |
Antinematodal Agents
Substances used in the treatment or control of nematode infestations. They are used also in veterinary practice. (See all compounds classified as Antinematodal Agents.)
ABOUT THIS PAGE
A Piperazine, Hexahydrate manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Piperazine, Hexahydrate, including repackagers and relabelers. The FDA regulates Piperazine, Hexahydrate manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Piperazine, Hexahydrate API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Piperazine, Hexahydrate supplier is an individual or a company that provides Piperazine, Hexahydrate active pharmaceutical ingredient (API) or Piperazine, Hexahydrate finished formulations upon request. The Piperazine, Hexahydrate suppliers may include Piperazine, Hexahydrate API manufacturers, exporters, distributors and traders.
Piperazine, Hexahydrate Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Piperazine, Hexahydrate GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Piperazine, Hexahydrate GMP manufacturer or Piperazine, Hexahydrate GMP API supplier for your needs.
A Piperazine, Hexahydrate CoA (Certificate of Analysis) is a formal document that attests to Piperazine, Hexahydrate's compliance with Piperazine, Hexahydrate specifications and serves as a tool for batch-level quality control.
Piperazine, Hexahydrate CoA mostly includes findings from lab analyses of a specific batch. For each Piperazine, Hexahydrate CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Piperazine, Hexahydrate may be tested according to a variety of international standards, such as European Pharmacopoeia (Piperazine, Hexahydrate EP), Piperazine, Hexahydrate JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Piperazine, Hexahydrate USP).
LOOKING FOR A SUPPLIER?
